Literature DB >> 6821861

Patterns of care outcome studies. Results of the national practice in cancer of the cervix.

G E Hanks, D F Herring, S Kramer.   

Abstract

This report summarizes the national data collected by the Patterns of Care Study in the process and outcome of care in the treatment of carcinoma of the cervix. Substantial variation was found from a consensus of best current management, although training facilities tended to score higher than nontraining on a compliance measure. Four year national averages for control of cervical cancer are: Stage I, 87%, Stage II, 66%, Stage III, 28%. Factors relating to recurrences include failure to use intracavitary irradiation, the type of equipment, the central dose, and Karnofsky Score. The presence of complications is associated with daily dose, lateral dose and central dose, among other factors, and was shown to be unacceptably high in Stage I.

Entities:  

Mesh:

Year:  1983        PMID: 6821861     DOI: 10.1002/1097-0142(19830301)51:5<959::aid-cncr2820510533>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Repair of chronic radiation wounds of the pelvis.

Authors:  S J Mathes; D J Hurwitz
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

2.  Iodine 125 interstitial irradiation for localized prostate cancer.

Authors:  P P Kumar; R R Good; F F Bartone
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

Review 3.  Brachytherapy in Gynecologic Cancers: Why Is It Underused?

Authors:  Kathy Han; Akila N Viswanathan
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

4.  Decreased morbidity and increased survival in cervical cancer treatment.

Authors:  P P Kumar; R R Good; J C Scott; E O Jones
Journal:  J Natl Med Assoc       Date:  1988-10       Impact factor: 1.798

Review 5.  American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.

Authors:  Jyoti Mayadev; Akila Viswanathan; Yu Liu; Chin-Shang Li; Kevin Albuquerque; Antonio L Damato; Sushil Beriwal; Beth Erickson
Journal:  Brachytherapy       Date:  2017 Jan - Feb       Impact factor: 2.362

Review 6.  Gastrointestinal toxicity associated to radiation therapy.

Authors:  Mario López Rodríguez; Margarita Martín Martín; Laura Cerezo Padellano; Alicia Marín Palomo; Yamile Ibáñez Puebla
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

Review 7.  External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications.

Authors:  Omar Mahmoud; Sarah Kilic; Atif J Khan; Sushil Beriwal; William Small
Journal:  Ann Transl Med       Date:  2017-05

8.  Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial.

Authors:  S Dinges; C Harder; R Wurm; A Buchali; J Blohmer; J Gellermann; P Wust; H Randow; V Budach
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

9.  Rapid emission angle selection for rotating-shield brachytherapy.

Authors:  Yunlong Liu; Ryan T Flynn; Wenjun Yang; Yusung Kim; Sudershan K Bhatia; Wenqing Sun; Xiaodong Wu
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

10.  Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer.

Authors:  Brandon M Barney; Ivy A Petersen; Sean C Dowdy; Jamie N Bakkum-Gamez; Kristi A Klein; Michael G Haddock
Journal:  Radiat Oncol       Date:  2013-04-08       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.